The clinical and financial burden of mood disorders : cost and outcome : Depressive disorders in the medically ill : expanding options for the consultation-liaison psychiatrist.
Depressive disorders are a chronic, recurrent, and severe burden to both patients and their families.
Depressive disorders represent a major national public health problem, ranking within the top 10 most costly diseases in the United States.
In 1990, depressive disorders afflicted at least II million Americans and cost the U.S. economy an estimated $44 billion.
In addition, affective disorders are associated with increased accident rates, increased rates of substance abuse (especially alcoholism), increased medical hospitalization, and an increase in somatic illnesses and outpatient medical utilization.
Despite their ranking as a major health problem, depressive disorders are often underdiagnosed and undertreated.
Brief treatment strategies that focus only on acute episodes are often ineffective and result in chronic impairment, impairing performance at work and socially.
Inadequate treatment increases costs, suffering, and lost productivity.
Recent data suggest that effective treatment of depression requires long-term, skillful follow-up and active pharmacotherapy.
Mots-clés Pascal : Etat dépressif, Trouble humeur, Analyse coût, Economie santé, Etats Unis, Amérique du Nord, Amérique, Suicide, Activité professionnelle, Traitement, Article synthèse, Homme
Mots-clés Pascal anglais : Depression, Mood disorder, Cost analysis, Health economy, United States, North America, America, Suicide, Professional activity, Treatment, Review, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0473360
Code Inist : 002B18H05B. Création : 01/03/1996.